ReP USP - Resultado da busca

Artigo de periodico
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: a report from the COVAD study (2023)
Shinjo, Samuel Katsuyuki ; Kim, Minchul; Hoff, Leonardo Santos; Misse, Rafael Giovani; Sen, Parikshit; Naveen, R; Day, Jessica; Cordeiro, Rafael Alves; Goncalves Junior, Jucier; Chatterjee, Tulika B
Source: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. Unidade: FM
Subjects: DOENÇAS AUTOIMUNES, DOENÇAS REUMÁTICAS, MIOSITE, DOR CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHINJO, Samuel Katsuyuki et al. Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: a report from the COVAD study. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, v. 26, n. 4, p. 727-739, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57842. Acesso em: 01 nov. 2024.
APA
Shinjo, S. K., Kim, M., Hoff, L. S., Misse, R. G., Sen, P., Naveen, R., et al. (2023). Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: a report from the COVAD study. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 26( 4), 727-739. doi:10.1111/1756-185X.14636
NLM
Shinjo SK, Kim M, Hoff LS, Misse RG, Sen P, Naveen R, Day J, Cordeiro RA, Goncalves Junior J, Chatterjee TB. Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: a report from the COVAD study [Internet]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2023 ; 26( 4): 727-739.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57842
Vancouver
Shinjo SK, Kim M, Hoff LS, Misse RG, Sen P, Naveen R, Day J, Cordeiro RA, Goncalves Junior J, Chatterjee TB. Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: a report from the COVAD study [Internet]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2023 ; 26( 4): 727-739.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57842
Artigo de periodico
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey (2023)
Hoff, Leonardo Santos; Ravichandran, Naveen; Shinjo, Samuel Katsuyuki ; Day, Jessica; Sen, Parikshit; Junior, Jucier Goncalves; Lilleker, James B.; Joshi, Mrudula; Agarwal, Vishwesh; Kardes, Sinan
Source: RHEUMATOLOGY INTERNATIONAL. Unidade: FM
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOFF, Leonardo Santos et al. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey. RHEUMATOLOGY INTERNATIONAL, v. 43, n. 1, p. 47-58, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57854. Acesso em: 01 nov. 2024.
APA
Hoff, L. S., Ravichandran, N., Shinjo, S. K., Day, J., Sen, P., Junior, J. G., et al. (2023). COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey. RHEUMATOLOGY INTERNATIONAL, 43( 1), 47-58. doi:10.1007/s00296-022-05229-7
NLM
Hoff LS, Ravichandran N, Shinjo SK, Day J, Sen P, Junior JG, Lilleker JB, Joshi M, Agarwal V, Kardes S. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey [Internet]. RHEUMATOLOGY INTERNATIONAL. 2023 ; 43( 1): 47-58.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57854
Vancouver
Hoff LS, Ravichandran N, Shinjo SK, Day J, Sen P, Junior JG, Lilleker JB, Joshi M, Agarwal V, Kardes S. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey [Internet]. RHEUMATOLOGY INTERNATIONAL. 2023 ; 43( 1): 47-58.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57854
Artigo de periodico
Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review (2023)
Souza, Fernando Henrique Carlos de ; Araujo, D. B. de; Hoff, Leonardo Santos ; Baldi, Bruno Guedes ; Faria, Marlise Sitima Mendes Simões ; Rocha Júnior, Laurindo Ferreira da ; Silva, L. R. S. Da; Pinto, Gustavo Luiz Behrens ; Bezerra, Mailze Campos ; Miossi, Renata ; Cordeiro, Rafael Alves ; Shinjo, Samuel Katsuyuki
Source: Reumatismo. Unidade: FM
Subjects: DOENÇAS PULMONARES INTERSTICIAIS, MIOSITE, DOENÇAS AUTOIMUNES, AUTOANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Fernando Henrique Carlos de et al. Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review. Reumatismo, v. 75, n. 1, p. 1-14, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53778. Acesso em: 01 nov. 2024.
APA
Souza, F. H. C. de, Araujo, D. B. de, Hoff, L. S., Baldi, B. G., Faria, M. S. M. S., Rocha Júnior, L. F. da, et al. (2023). Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review. Reumatismo, 75( 1), 1-14. doi:10.4081/reumatismo.2023.1571
NLM
Souza FHC de, Araujo DB de, Hoff LS, Baldi BG, Faria MSMS, Rocha Júnior LF da, Silva LRSD, Pinto GLB, Bezerra MC, Miossi R, Cordeiro RA, Shinjo SK. Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review [Internet]. Reumatismo. 2023 ; 75( 1): 1-14.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53778
Vancouver
Souza FHC de, Araujo DB de, Hoff LS, Baldi BG, Faria MSMS, Rocha Júnior LF da, Silva LRSD, Pinto GLB, Bezerra MC, Miossi R, Cordeiro RA, Shinjo SK. Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review [Internet]. Reumatismo. 2023 ; 75( 1): 1-14.[citado 2024 nov. 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53778
Artigo de periodico
Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study (2022)
Truzzi, Natassia Cristina Carboni; Hoff, Leonardo Santos; Borges, Isabela Bruna Pires; Souza, Fernando Henrique Carlos de; Shinjo, Samuel Katsuyuki
Source: Advances in rheumatology. Unidade: FM
Subjects: MIOSITE, MANIFESTAÇÕES CUTÂNEAS, ANTICORPOS, ESTUDOS LONGITUDINAIS, BRASILEIROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRUZZI, Natassia Cristina Carboni et al. Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study. Advances in rheumatology, v. 62, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1186/s42358-022-00276-x. Acesso em: 01 nov. 2024.
APA
Truzzi, N. C. C., Hoff, L. S., Borges, I. B. P., Souza, F. H. C. de, & Shinjo, S. K. (2022). Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study. Advances in rheumatology, 62( 1). doi:10.1186/s42358-022-00276-x
NLM
Truzzi NCC, Hoff LS, Borges IBP, Souza FHC de, Shinjo SK. Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s42358-022-00276-x
Vancouver
Truzzi NCC, Hoff LS, Borges IBP, Souza FHC de, Shinjo SK. Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s42358-022-00276-x
Artigo de periodico
Characterization of patients with dermatomyositis according to anti-melanoma differentiation-associated gene-5 autoantibodies in Centers from 3 Latin American Countries: a cohort study (2022)
Pallo, Pablo Arturo Olivo; Hoff, Leonardo Santos; Borges, Isabela Bruna Pires; Torres-Ruiz, Jiram; Cassiano-Quezada, Fabiola; Granel, Amelia; Gomez, Graciela; Pisoni, Cecilia; Gomez, Ramiro; Shinjo, Samuel Katsuyuki
Source: Jcr-journal of clinical rheumatology. Unidade: FM
Subjects: MIOSITE, ESTUDOS DE COORTES, DOENÇAS PULMONARES INTERSTICIAIS, DOENÇA PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALLO, Pablo Arturo Olivo et al. Characterization of patients with dermatomyositis according to anti-melanoma differentiation-associated gene-5 autoantibodies in Centers from 3 Latin American Countries: a cohort study. Jcr-journal of clinical rheumatology, v. 28, n. 2, p. E444-E448, 2022Tradução . . Disponível em: https://doi.org/10.1097/RHU.0000000000001756. Acesso em: 01 nov. 2024.
APA
Pallo, P. A. O., Hoff, L. S., Borges, I. B. P., Torres-Ruiz, J., Cassiano-Quezada, F., Granel, A., et al. (2022). Characterization of patients with dermatomyositis according to anti-melanoma differentiation-associated gene-5 autoantibodies in Centers from 3 Latin American Countries: a cohort study. Jcr-journal of clinical rheumatology, 28( 2), E444-E448. doi:10.1097/RHU.0000000000001756
NLM
Pallo PAO, Hoff LS, Borges IBP, Torres-Ruiz J, Cassiano-Quezada F, Granel A, Gomez G, Pisoni C, Gomez R, Shinjo SK. Characterization of patients with dermatomyositis according to anti-melanoma differentiation-associated gene-5 autoantibodies in Centers from 3 Latin American Countries: a cohort study [Internet]. Jcr-journal of clinical rheumatology. 2022 ; 28( 2): E444-E448.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1097/RHU.0000000000001756
Vancouver
Pallo PAO, Hoff LS, Borges IBP, Torres-Ruiz J, Cassiano-Quezada F, Granel A, Gomez G, Pisoni C, Gomez R, Shinjo SK. Characterization of patients with dermatomyositis according to anti-melanoma differentiation-associated gene-5 autoantibodies in Centers from 3 Latin American Countries: a cohort study [Internet]. Jcr-journal of clinical rheumatology. 2022 ; 28( 2): E444-E448.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1097/RHU.0000000000001756
Artigo de periodico
Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies (2019)
Souza, Jean Marcos de; Hoff, Leonardo Santos; Shinjo, Samuel Katsuyuki
Source: Rheumatology international. Unidade: FM
Subjects: IMUNOGLOBULINAS INTRAVENOSAS, DOENÇAS MUSCULARES, HORMÔNIOS GLICOCORTICOIDES, IMUNOTERAPIA, RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Jean Marcos de e HOFF, Leonardo Santos e SHINJO, Samuel Katsuyuki. Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies. Rheumatology international, v. 39, n. 7, p. 1201-1212, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00296-019-04254-3. Acesso em: 01 nov. 2024.
APA
Souza, J. M. de, Hoff, L. S., & Shinjo, S. K. (2019). Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies. Rheumatology international, 39( 7), 1201-1212. doi:10.1007/s00296-019-04254-3
NLM
Souza JM de, Hoff LS, Shinjo SK. Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies [Internet]. Rheumatology international. 2019 ; 39( 7): 1201-1212.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00296-019-04254-3
Vancouver
Souza JM de, Hoff LS, Shinjo SK. Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies [Internet]. Rheumatology international. 2019 ; 39( 7): 1201-1212.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00296-019-04254-3

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Funding Agencies

Non normalized affiliation